ATE328102T1 - Verfahren zur herstellung von proteine - Google Patents
Verfahren zur herstellung von proteineInfo
- Publication number
- ATE328102T1 ATE328102T1 AT02251539T AT02251539T ATE328102T1 AT E328102 T1 ATE328102 T1 AT E328102T1 AT 02251539 T AT02251539 T AT 02251539T AT 02251539 T AT02251539 T AT 02251539T AT E328102 T1 ATE328102 T1 AT E328102T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- recovered
- producing proteins
- desired protein
- particles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001060973A JP4655388B2 (ja) | 2001-03-05 | 2001-03-05 | タンパク質の生産方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE328102T1 true ATE328102T1 (de) | 2006-06-15 |
Family
ID=18920336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02251539T ATE328102T1 (de) | 2001-03-05 | 2002-03-05 | Verfahren zur herstellung von proteine |
Country Status (8)
Country | Link |
---|---|
US (2) | US20030104580A1 (de) |
EP (2) | EP1637604A3 (de) |
JP (1) | JP4655388B2 (de) |
KR (1) | KR20020071476A (de) |
AT (1) | ATE328102T1 (de) |
AU (1) | AU785338B2 (de) |
CA (1) | CA2374420A1 (de) |
DE (1) | DE60211772T2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697394B2 (en) | 2000-06-28 | 2014-04-15 | Glycofi, Inc. | Production of modified glycoproteins having multiple antennary structures |
US7449308B2 (en) | 2000-06-28 | 2008-11-11 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
WO2002000879A2 (en) | 2000-06-28 | 2002-01-03 | Glycofi, Inc. | Methods for producing modified glycoproteins |
US7598055B2 (en) * | 2000-06-28 | 2009-10-06 | Glycofi, Inc. | N-acetylglucosaminyltransferase III expression in lower eukaryotes |
US7332299B2 (en) | 2003-02-20 | 2008-02-19 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
US9333249B2 (en) | 2006-02-09 | 2016-05-10 | Educational Foundation Jichi Medical University | Recombinant baculovirus vaccine |
TWI477602B (zh) | 2006-02-09 | 2015-03-21 | Educational Foundation Jichi Medical Univ | Novel viral vector |
JP5445131B2 (ja) * | 2006-12-22 | 2014-03-19 | 富士レビオ株式会社 | バイオセンサおよびバイオセンサチップ、ならびに標的分子を感知するためのバイオセンサチップの製造方法 |
CN101688253A (zh) * | 2007-07-12 | 2010-03-31 | 新泽西内科与牙科大学 | 抗毒素不稳定化技术 |
JP2010273676A (ja) * | 2009-04-28 | 2010-12-09 | Univ Of Tokyo | 転移基で修飾された基質の製造方法 |
US20110201086A1 (en) | 2010-02-12 | 2011-08-18 | Otsuka Pharmaceutical Co., Ltd. | Method for producing recombinant virus |
KR101843614B1 (ko) * | 2012-05-23 | 2018-03-29 | 제넨테크, 인크. | 치료제의 선택 방법 |
CN104955902B (zh) * | 2012-10-23 | 2018-07-13 | 法国巴黎市立高等工业物理化学学院 | 包含可多次顺序形成和断开的可逆共价键的颗粒 |
CN111808884A (zh) * | 2020-07-23 | 2020-10-23 | 云舟生物科技(广州)有限公司 | 杆状病毒表达系统及其构建方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2761994B1 (fr) * | 1997-04-11 | 1999-06-18 | Centre Nat Rech Scient | Preparation de recepteurs membranaires a partir de baculovirus extracellulaires |
-
2001
- 2001-03-05 JP JP2001060973A patent/JP4655388B2/ja not_active Expired - Fee Related
-
2002
- 2002-03-04 CA CA002374420A patent/CA2374420A1/en not_active Abandoned
- 2002-03-05 KR KR1020020011610A patent/KR20020071476A/ko not_active Application Discontinuation
- 2002-03-05 EP EP05021610A patent/EP1637604A3/de not_active Withdrawn
- 2002-03-05 AT AT02251539T patent/ATE328102T1/de not_active IP Right Cessation
- 2002-03-05 DE DE60211772T patent/DE60211772T2/de not_active Expired - Fee Related
- 2002-03-05 AU AU21282/02A patent/AU785338B2/en not_active Ceased
- 2002-03-05 EP EP02251539A patent/EP1239047B1/de not_active Expired - Lifetime
- 2002-03-05 US US10/087,775 patent/US20030104580A1/en not_active Abandoned
-
2004
- 2004-08-02 US US10/903,768 patent/US20050064557A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002253263A (ja) | 2002-09-10 |
EP1239047B1 (de) | 2006-05-31 |
KR20020071476A (ko) | 2002-09-12 |
DE60211772D1 (de) | 2006-07-06 |
EP1637604A2 (de) | 2006-03-22 |
EP1637604A3 (de) | 2006-06-07 |
US20050064557A1 (en) | 2005-03-24 |
EP1239047A2 (de) | 2002-09-11 |
EP1239047A3 (de) | 2004-03-24 |
US20030104580A1 (en) | 2003-06-05 |
JP4655388B2 (ja) | 2011-03-23 |
AU2128202A (en) | 2002-09-12 |
DE60211772T2 (de) | 2007-05-24 |
CA2374420A1 (en) | 2002-09-05 |
AU785338B2 (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE328102T1 (de) | Verfahren zur herstellung von proteine | |
DE69934269D1 (de) | Verfahren zur Reinigung und Isolierung von Viren, aus Pflanzenquellen | |
ATE405644T1 (de) | Verfahren zur herstellung und reinigung von erythropoietin | |
ATE438722T1 (de) | Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein | |
ATE553125T1 (de) | Herstellung eines multimeren proteins durch zellfusionsverfahren | |
ATE542904T1 (de) | Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen | |
DE60236641D1 (de) | Recombinante virale schalter zur kontrolle von genexpression in pflanzen | |
DE602005022387D1 (de) | Verfahren zur Herstellung von Dipeptiden | |
HK1108713A1 (en) | Animal protein free media for cultivation of cells | |
DE60313188D1 (de) | Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden | |
ATE294229T1 (de) | Verfahren zur trocknung von kompetenten zellen | |
DE69939901D1 (de) | Verfahren und materialien zur herstellung von glucosamin | |
ATE404588T1 (de) | Verfahren zur herstellung von chondroitinsulfaten aus k4-polysaccharid und so hergestellte produkte | |
ATE369384T1 (de) | Expression und export von interferon-alpha proteinen als fc fusionsproteine | |
DE68929115D1 (de) | Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe | |
ATE521695T1 (de) | Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie | |
ATE279441T1 (de) | Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen | |
ATE417605T1 (de) | Proteine die cross-beta-struktur enthaltendes amyloid binden, sowie verfahren zur modulation der cross-beta-struktur, ihrer bildung und der damit zusammenhängenden toxizität | |
DE10390418D2 (de) | Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen | |
DE69835813D1 (de) | Verfahren zur kultivierung von zellen und zur vermehrung von viren | |
WO2007130154A8 (en) | Recombinant production of heparin binding proteins | |
ATE147437T1 (de) | Verfahren zur endoproteolytischen bearbeitung von (vorläufer)proteinen und zur (mikro)biologischen herstellung | |
DE69430975D1 (de) | Verfahren zur Herstellung von Proteinen | |
ATE513033T1 (de) | Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen | |
WO2002088338A3 (fr) | Procede de replication du virus de l'hepatite c |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |